Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Tim Van Hauwermeiren$22.1B
Market Cap • 24/04/20242008
(há 16 anos)
2017
(7 years ago)
NASDAQ
Listagem
Amsterdam
Sede • NH843
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ARGXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.